These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16733232)

  • 21. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study.
    Devereux RB; Roman MJ; Paranicas M; Lee ET; Welty TK; Fabsitz RR; Robbins D; Rhoades ER; Rodeheffer RJ; Cowan LD; Howard BV
    Am Heart J; 2001 Mar; 141(3):439-46. PubMed ID: 11231443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished contractile reserve in patients with left ventricular hypertrophy and increased end-systolic stress during Dobutamine stress echocardiography.
    Fontanet HL; Pérez JE; Dávila-Román VG
    Am J Cardiol; 1996 Nov; 78(9):1029-35. PubMed ID: 8916483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in systolic heart failure in the elderly: the prognostic importance of left ventricular mass in women.
    Mejhert M; Kahan T; Edner M; Persson HE
    J Womens Health (Larchmt); 2008 Apr; 17(3):373-81. PubMed ID: 18338962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.
    Rzeznik D; Przewlocki T; Kablak-Ziembicka A; Kozanecki A; Roslawiecka A; Lach J; Tracz W; Podolec P
    J Vasc Surg; 2011 Mar; 53(3):692-7. PubMed ID: 21129903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data.
    Elhendy A; Modesto KM; Mahoney DW; Khandheria BK; Seward JB; Pellikka PA
    J Am Coll Cardiol; 2003 Jan; 41(1):129-35. PubMed ID: 12570955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of central systolic blood pressure in LV diastolic dysfunction and CV mortality.
    Choi SR; Lee YK; Cho Park H; Kim DH; Cho A; Kang MK; Choi S
    PLoS One; 2021; 16(5):e0250653. PubMed ID: 33951046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Ali S; Schiller NB; Whooley MA
    J Card Fail; 2006 Oct; 12(8):601-7. PubMed ID: 17045178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of left ventricular mass change during treatment of hypertension.
    Devereux RB; Wachtell K; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris K; Aurup P; Dahlöf B
    JAMA; 2004 Nov; 292(19):2350-6. PubMed ID: 15547162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.
    Hayashi SY; Rohani M; Lindholm B; Brodin LA; Lind B; Barany P; Alvestrand A; Seeberger A
    Nephrol Dial Transplant; 2006 Jan; 21(1):125-32. PubMed ID: 16221719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study.
    Devereux RB; Roman MJ; Palmieri V; Liu JE; Lee ET; Best LG; Fabsitz RR; Rodeheffer RJ; Howard BV
    Am Heart J; 2003 Sep; 146(3):527-34. PubMed ID: 12947374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors in Thai elderly men and women.
    Chantra S; Bhuthong B
    J Med Assoc Thai; 2000 Sep; 83(9):1082-94. PubMed ID: 11075977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paradoxic changes in the morphology of blood pressure wave in hypertensive heart diseases].
    Chevallier M; Siche JP; Tremel F; de Gaudemaris R; Boutelant S; Mallion JM
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1135-9. PubMed ID: 8572860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
    Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
    Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal regional left ventricular mechanics in treated hypertensive patients with 'normal left ventricular function'.
    Xiao HB; Kaleem S; McCarthy C; Rosen SD
    Int J Cardiol; 2006 Oct; 112(3):316-21. PubMed ID: 16309760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ambulatory arterial pressure and left ventricular hypertrophy in untreated hypertensive patients].
    Pascual JM; Baldó E; Bertolín V; Rovira E; Gonzalvo F; González C; Redon J
    Med Clin (Barc); 1999 Feb; 112(5):166-70. PubMed ID: 10091209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.